PRESS RELEASE published on 02/12/2026 at 21:16, 7 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc. Detailed Form 8.3 filing reveals ownership details and recent dealings The Vanguard Group, Inc. Form 8.3 Stake Disclosure Dealings JTC Plc
BRIEF published on 02/12/2026 at 21:15, 7 months 5 days ago The Vanguard Group Discloses Position in International Personal Finance Form 8.3 Takeover Code Securities Disclosure Vanguard Group International Personal Finance
PRESS RELEASE published on 02/12/2026 at 21:15, 7 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses a 1.25% stake in Bluefield Solar Income Fund Limited as of 11 Feb 2026, with 30,476 shares purchased at 0.76 GBP per share The Vanguard Group Financial Disclosure Share Purchase Stake Disclosure Bluefield Solar Income Fund Limited
BRIEF published on 02/12/2026 at 21:15, 7 months 5 days ago The Vanguard Group Discloses Position in Picton Property Income Limited Securities Disclosure Takeover Code Vanguard Picton Property
PRESS RELEASE published on 02/12/2026 at 21:14, 7 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% interest in Beazley plc through Form 8.3. Transactions include purchases and sales of 5p ordinary shares Transactions The Vanguard Group, Inc. Form 8.3 Disclosure Beazley Plc
BRIEF published on 02/12/2026 at 21:14, 7 months 5 days ago The Vanguard Group Discloses Position in NCC Group plc Disclosure Takeover Code Vanguard Group Shareholding NCC Group
PRESS RELEASE published on 02/12/2026 at 21:13, 7 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.61% interest in Spire Healthcare Group plc as per Form 8.3 submitted under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Takeover Code Interest Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 02/12/2026 at 21:13, 7 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc The Vanguard Group, Inc. discloses a 1.01% interest in Oxford Biomedica plc. Purchase of 3,890 securities at 8.16 GBP per unit on 11 Feb 2026 Securities Disclosure Vanguard Group Purchase Oxford Biomedica Plc
PRESS RELEASE published on 02/12/2026 at 21:11, 7 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.92% stake in Just Group plc as of 11th Feb 2026. Details of securities interests and transactions provided in Form 8.3 Securities Form 8.3 Disclosure The Vanguard Group Just Group Plc
PRESS RELEASE published on 02/12/2026 at 21:10, 7 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses an open position of 1.13% in International Personal Finance plc's 10p ordinary shares on 11th February 2026 Relevant Securities Takeover Code Vanguard Group Open Position Disclosure International Personal Finance Plc
Published on 09/18/2026 at 14:30, 19 minutes ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/18/2026 at 13:30, 1 hour 19 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 8 hours 19 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 13 hours 54 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 14:25, 23 minutes ago Huawei Unveils Innovative Immersive Telepresence Solution That Offers Immersive Experiences and Intelligent Services
Published on 09/18/2026 at 13:52, 57 minutes ago New rules for green claims. Does eco-friendly also mean animal-friendly?
Published on 09/18/2026 at 13:51, 57 minutes ago Completion of the Acquisition of a Majority Stake in Jucari Global Pty Ltd
Published on 09/18/2026 at 13:50, 58 minutes ago Omio expands premium overnight travel options with Twiliner
Published on 09/18/2026 at 13:30, 1 hour 19 minutes ago EQS-Adhoc: Sibanye Gold Limited: Notice to Bondholders
Published on 09/17/2026 at 17:40, 21 hours 9 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 21 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 7 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification